Patent · US Active

Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability

US11382877B2 · kind B2 · utility

1Cited by
3References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 13, 2018
Grant dateJul 12, 2022
Priority date—
Expiry dateJan 3, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone and pharmaceutically acceptable salts thereof are described as well as methods of their use, and a dose regimen of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone, sodium salt to reduce the incidence of urothelial toxicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.